ASCO and CollabRx Partner to Develop Online Apps for Cancer Treatment Targeted to Molecular Subtypes

ASCO and CollabRX announced a partnership that will focus, at first, on CollabRx’s Targeted Therapy Finder -- Melanoma, a web application that allows patients to search for treatments based on the molecular characteristics of their cancer.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.